Literature DB >> 13189917

Macroglobulinemia; clinical features and differential diagnosis.

H WILDE, A L HITZELBERGER.   

Abstract

Entities:  

Keywords:  SERUM GLOBULIN

Mesh：

Substances：

Year:  1954        PMID： 13189917

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  [Case of a cryoglobulinemic abdominal intermittent dyspragia in the course of a so-called essential cryoglobulinemia].

Authors:  E SLADKI; A WIERZBOWSKA; H E SCHULTZE
Journal:  Klin Wochenschr       Date:  1959-07-01

2.  A case of macroglobulinemia.

Authors:  M SERRATTO; J F ELLIOTT
Journal:  Can Med Assoc J       Date:  1961-10-21       Impact factor: 8.262

3.  Effect of prednisolone on anaemia associated with macroglobulinemia.

Authors:  W R PITNEY; W J O'SULLIVAN; J A OWEN
Journal:  Br Med J       Date:  1958-12-20

4.  Macroglobulinaemia with cryoglobulinaemia in a case of acquired syphilis.

Authors:  W E HIRTE
Journal:  Can Med Assoc J       Date:  1959-05-15       Impact factor: 8.262

5.  MACROGLOBULINAEMIA.

Authors: 
Journal:  Br Med J       Date:  1956-06-23

6.  Metabolic disturbances in disseminated neoplastic disease.

Authors:  W P L MYERS
Journal:  Bull N Y Acad Med       Date:  1957-10

7.  Macroglobulinaemia of Waldenström.

Authors:  D G FERRIMAN; A B ANDERSON
Journal:  Br Med J       Date:  1956-08-18

8.  Macroglobulinaemia; effect of macroglobulins on prothrombin conversion accelerators.

Authors:  L A LONG; J L RIOPELLE; M FRANCOEUR; A PARE; P POIRIER; M GEORGESCO; G COLPRON
Journal:  Can Med Assoc J       Date:  1955-11-01       Impact factor: 8.262

9.  Waldenströms purpura hyperglobulinaemica associated with macroglobulins.

Authors:  J M BEAUREGARD; J G LAURIN; G PROVOST
Journal:  Can Med Assoc J       Date:  1957-02-15       Impact factor: 8.262

10.  Physical properties of the red cell agglutinins in acquired hemolytic anemia.

Authors:  H H FUDENBERG; H G KUNKEL
Journal:  J Exp Med       Date:  1957-11-01       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.